middle.news
Dimerix Recruits First Paediatric Patient in Pivotal ACTION3 Kidney Trial
8:24am on Thursday 16th of January, 2025 AEDT
•
Biopharmaceutical
Read Story
Dimerix Recruits First Paediatric Patient in Pivotal ACTION3 Kidney Trial
8:24am on Thursday 16th of January, 2025 AEDT
Key Points
First paediatric patient recruited in UK for ACTION3 Phase 3 trial
Trial includes 19 specialist paediatric sites across four countries
DMX-200 dose for children matches adult dosing based on safety data
Interim data collection expected August 2025; full recruitment by late Q3 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Dimerix (ASX:DXB)
OPEN ARTICLE